Luis Aguirre, MD, Moffitt Cancer Center, Tampa, FL, comments on the biology and clinical phenotypes of chronic myelomonocytic leukemia (CMML) and discusses the potential of drugs like JAK2 inhibitors that are currently under investigation for this disease. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.